Pharmacologic treatment of intermittent claudication

Area of Science:

• Vascular Medicine
• Pharmacology

Background:

• Intermittent claudication is a common symptom of peripheral artery disease.
• Limited effective pharmacological treatments exist for improving walking capacity.

Purpose of the Study:

• To evaluate the efficacy of pentoxifylline in treating severe intermittent claudication.
• To assess the impact of pentoxifylline on claudication distances.

Main Methods:

• A 24-week, randomized, double-blind, parallel-group study.
• Twenty-six patients with severe short-distance claudication were enrolled.
• Standardized treadmill testing measured initial and absolute claudication distances.

Main Results:

• Pentoxifylline treatment led to statistically significant improvements in both initial and absolute claudication distances.
• The only reported drug side effect was nausea.

Conclusions:

• Pentoxifylline demonstrates efficacy in improving walking distance for patients with intermittent claudication.
• Pentoxifylline is a potential therapeutic option for managing intermittent claudication symptoms.